Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Quantum Biopharma ( (TSE:QNTM) ) has issued an update.
Quantum BioPharma’s licensee, Unbuzzd Wellness Inc., is hosting a live webinar to discuss its innovative beverage, unbuzzd™, which accelerates alcohol metabolism and reduces hangover symptoms. The webinar aims to attract investors for a $5 million fundraising effort to expand distribution and retail sales. Unbuzzd’s product is backed by clinical trials showing significant improvements in alcohol metabolism and hangover relief, positioning it as a promising player in the wellness and recovery supplement industry.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative assets and biotech solutions for treating neurodegenerative, metabolic, and alcohol misuse disorders. The company has a range of drug candidates in various stages of development.
Average Trading Volume: 4,139
Technical Sentiment Signal: Buy
Current Market Cap: C$97.3M
Find detailed analytics on QNTM stock on TipRanks’ Stock Analysis page.